Can a new serum tighten skin for women on ozempic?

NCT ID NCT07558603

Not yet recruiting Symptom relief Sponsor: Goldman, Butterwick, Fitzpatrick and Groff Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a topical serum called AGE serum on 50 post-menopausal women (ages 45-65) who are taking GLP-1 drugs like Ozempic or Wegovy, with half also on hormone therapy. The goal is to see if the serum safely improves skin firmness, fine lines, and radiance. Researchers will use skin grading scales and photos to measure changes over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: AGE serum (30% Proxylane, fruit-derived flavonoids, Cassia alata extract)
What this could lead to: If it works, this could offer a topical option to improve skin firmness, texture, and radiance for women experiencing skin laxity while on GLP-1 medications.
What could go wrong: This is a small, early-phase study with only 50 participants and no control group. Results may not apply to everyone, and the serum's effects on skin are subjective.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LAXITY; SKIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cutis laxa Weight Loss

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LAXITY; SKIN

Contacts and locations

Locations

West Dermatology Research Center

San Diego, California, 92121, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.